Immunohistochemical and Functional Characterization of Peptide, Organic Cation, Neutral and Basic Amino Acid, and Monocarboxylate Drug Transporters in Human Ocular Tissues

Overview

Journal Drug Metab Dispos

Specialty Pharmacology

Date 2012 Nov 22

PMID 23169611

Citations 6

Authors

Rajendra S Kadam

Sunil K Vooturi

Uday B Kompella

Affiliations

Soon will be listed here.

Abstract

Since there is paucity of information on solute transporters in human ocular tissues, the aim of this study was immunohistochemical and functional characterization of peptide transporters (PEPT), organic cation transporters (OCTs), neutral and basic amino acid transporters (ATB(0,+)), and monocarboxylate transporters (MCTs) in human ocular barriers. Immunohistochemical localization of transporters was achieved using 5-µm-thick paraffin-embedded sections of whole human eyes. In vitro transport studies were carried out across human cornea and sclera-choroid-retinal pigment epithelium (SCRPE) using a cassette of specific substrates in the presence and absence of inhibitors to determine the role of transporters in transtissue solute delivery. Immunohistochemistry showed the expression of PEPT-1, PEPT-2, ATB(0,+), OCT-1, OCT-2, MCT-1, and MCT-3 in human ocular tissues. PEPT-1, PEPT-2, OCT-1, MCT-1, and ATB(0,+) expression was evident in the cornea, conjunctiva, ciliary epithelium, and neural retina. Expression of PEPT-1, PEPT-2, and OCT-1 was evident in choroid tissue as well. OCT-2 expression could be seen in the corneal and conjunctival epithelia, whereas MCT-3 expression was confined to the RPE layer. OCT-2 expression was evident in conjunctival blood vessel walls, whereas PEPT-1, PEPT-2, and OCT-1 were expressed in the choroid. Preliminary transport studies indicated inward transport of Gly-Sar (PEPT substrate), 1-methyl-4-phenylpyridinium (MPP+) (OCT substrate), and l-tryptophan (ATB(0,+) substrate) across cornea as well as SCRPE. For phenylacetic acid (MCT substrate), transporter-mediated inward transport across the cornea and outward transport across SCRPE were evident. Thus, PEPT, OCT, and ATB(0,+) are influx transporters present in human ocular barriers, and they can potentially be used for transporter-guided retinal drug delivery after topical, transscleral, and systemic administrations.

Citing Articles

High Throughput Screening of Valganciclovir in Acidic Microenvironments of Polyester Thin Films.

Schaller T, Wenner T, Agrawal R, Teoh S, Phua L, Loo J Materials (Basel). 2017; 8(4):1714-1728.

PMID: 28788027 PMC: 5507036. DOI: 10.3390/ma8041714.

Prodrug approach to improve absorption of prednisolone.

Sheng Y, Yang X, Pal D, Mitra A Int J Pharm. 2015; 487(1-2):242-9.

PMID: 25888804 PMC: 4535455. DOI: 10.1016/j.ijpharm.2015.04.029.

Drug transporters in the central nervous system.

Stieger B, Gao B Clin Pharmacokinet. 2015; 54(3):225-42.

PMID: 25647629 DOI: 10.1007/s40262-015-0241-y.

Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells.

Chan T, Zhu L, Madigan M, Wang K, Shen W, Gillies M Br J Pharmacol. 2015; 172(9):2343-53.

PMID: 25560245 PMC: 4403098. DOI: 10.1111/bph.13060.

Monocarboxylate transporter mediated uptake of moxifloxacin on human retinal pigmented epithelium cells.

Barot M, Gokulgandhi M, Agrahari V, Pal D, Mitra A J Pharm Pharmacol. 2013; 66(4):574-83.

PMID: 24102496 PMC: 4407660. DOI: 10.1111/jphp.12139.

References

Zhang T, Xiang C, Gale D, Carreiro S, Wu E, Zhang E . Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition. Drug Metab Dispos. 2008; 36(7):1300-7. DOI: 10.1124/dmd.108.021121. View

Pedersen J, Matsson P, Bergstrom C, Norinder U, Hoogstraate J, Artursson P . Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008; 51(11):3275-87. DOI: 10.1021/jm7015683. View

Biegel A, Knutter I, Hartrodt B, Gebauer S, Theis S, Luckner P . The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids. 2006; 31(2):137-56. DOI: 10.1007/s00726-006-0331-0. View

Jain-Vakkalagadda B, Pal D, Gunda S, Nashed Y, Ganapathy V, Mitra A . Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Mol Pharm. 2005; 1(5):338-46. DOI: 10.1021/mp0499499. View

Karunakaran S, Umapathy N, Thangaraju M, Hatanaka T, Itagaki S, Munn D . Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. Biochem J. 2008; 414(3):343-55. DOI: 10.1042/BJ20080622. View

Gynther M, Laine K, Ropponen J, Leppanen J, Mannila A, Nevalainen T . Large neutral amino acid transporter enables brain drug delivery via prodrugs. J Med Chem. 2008; 51(4):932-6. DOI: 10.1021/jm701175d. View

Kompella U, Kadam R, Lee V . Recent advances in ophthalmic drug delivery. Ther Deliv. 2011; 1(3):435-56. PMC: 3051398. DOI: 10.4155/TDE.10.40. View

Xu S, Flanagan J, Simmons P, Vehige J, Willcox M, Garrett Q . Transport of L-carnitine in human corneal and conjunctival epithelial cells. Mol Vis. 2010; 16:1823-31. PMC: 2956661. View

Jong N, Nakanishi T, Liu J, Tamai I, McKeage M . Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons. J Pharmacol Exp Ther. 2011; 338(2):537-47. DOI: 10.1124/jpet.111.181297. View

10.

Jonker J, Schinkel A . Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther. 2003; 308(1):2-9. DOI: 10.1124/jpet.103.053298. View

11.

Kimura N, Okuda M, Inui K . Metformin transport by renal basolateral organic cation transporter hOCT2. Pharm Res. 2005; 22(2):255-9. DOI: 10.1007/s11095-004-1193-3. View

12.

Majumdar S, Hingorani T, Srirangam R, Gadepalli R, Rimoldi J, Repka M . Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement. Pharm Res. 2008; 26(5):1261-9. PMC: 2664401. DOI: 10.1007/s11095-008-9730-0. View

13.

Kansara V, Hao Y, Mitra A . Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina. J Ocul Pharmacol Ther. 2007; 23(4):321-34. DOI: 10.1089/jop.2006.0150. View

14.

Ganapathy M, Ganapathy V . Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs. Curr Drug Targets Immune Endocr Metabol Disord. 2005; 5(4):357-64. DOI: 10.2174/156800805774912953. View

15.

Garrett Q, Xu S, Simmons P, Vehige J, Flanagan J, Willcox M . Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. Invest Ophthalmol Vis Sci. 2008; 49(11):4844-9. DOI: 10.1167/iovs.07-1528. View

16.

Basu S, Haworth I, Bolger M, Lee V . Proton-driven dipeptide uptake in primary cultured rabbit conjunctival epithelial cells. Invest Ophthalmol Vis Sci. 1998; 39(12):2365-73. View

17.

Hosoya K, Kondo T, Tomi M, Takanaga H, Ohtsuki S, Terasaki T . MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina. Pharm Res. 2002; 18(12):1669-76. DOI: 10.1023/a:1013310210710. View

18.

Brandsch M, Knutter I, Thunecke F, Hartrodt B, Born I, Borner V . Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter. Eur J Biochem. 1999; 266(2):502-8. DOI: 10.1046/j.1432-1327.1999.00885.x. View

19.

Giacomini K, Huang S, Tweedie D, Benet L, Brouwer K, Chu X . Membrane transporters in drug development. Nat Rev Drug Discov. 2010; 9(3):215-36. PMC: 3326076. DOI: 10.1038/nrd3028. View

20.

Smith D, Johanson C, Keep R . Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev. 2004; 56(12):1765-91. DOI: 10.1016/j.addr.2004.07.008. View